JUPITER — Jupiter Bioscience Income Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual income statement for Jupiter Bioscience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2007 March 31st | 2008 March 31st | 2009 March 31st | 2010 March 31st | 2011 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Other Revenue | |||||
| Total Revenue | 1,214 | 1,557 | 1,799 | 2,327 | 3,314 |
| Cost of Revenue | |||||
| Gross Profit | 677 | 916 | 1,140 | 1,546 | 1,963 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 944 | 1,212 | 1,421 | 1,836 | 2,731 |
| Operating Profit | 271 | 345 | 378 | 491 | 583 |
| Net Income Before Taxes | 271 | 345 | 378 | 491 | 583 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 202 | 297 | 330 | 425 | 514 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 202 | 297 | 330 | 425 | 514 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 202 | 297 | 330 | 425 | 514 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 20.5 | 19.7 | 19.7 | 23.2 | 7.96 |
| Dividends per Share |